Vimarsana
Biggest News Aggregation in the World

Avedro Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Avedro Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Avedro Inc Today - Breaking & Trending Today

Glaukos Announces First Quarter 2024 Financial Results - Vimarsana News

Glaukos Announces First Quarter 2024 Financial Results

Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...

Glaukos Announces Third Quarter 2023 Financial Results - Vimarsana News

Glaukos Announces Third Quarter 2023 Financial Results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the third quarter ended September 30, 2023. Key h...

Growing Demand for Painless LASIK Surgeries Drives Opportunities in the Global Refractive Surgery Devices Market 2023-2030 - Vimarsana News

Growing Demand for Painless LASIK Surgeries Drives Opportunities in the Global Refractive Surgery Devices Market 2023-2030

Global Refractive Surgery Devices Market Global Refractive Surgery Devices Market Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Refractive Surgery Devices Market by Product Type (Aberrometers, Microkeratome, Ophthalmic Laser), Application (Astigmatism, Dry Eyes, Farsightedness), End-Use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering. The Global Refractive Surgery Devices Market

Source: yahoo.com
Glaukos Announces Second Quarter 2023 Financial Results - Vimarsana News

Glaukos Announces Second Quarter 2023 Financial Results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the second quarter ended June 30, 2023. Key highl...

Glaukos Announces First Quarter 2023 Financial Results - Vimarsana News

Glaukos Announces First Quarter 2023 Financial Results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2023. Key highl...